Effects of donepezil on cortical activation in mild cognitive impairment: A pilot double-blind placebo-controlled trial using functional MR imaging

American Journal of Neuroradiology

Volumn 30, Issue 2, 2009, Pages 411-416

  Petrella, J R ^a,b   Prince, S E ^a   Krishnan, S ^a   Husn, H ^b   Kelley, L ^b   Doraiswamy, P M ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL; OXYGEN; PLACEBO;

AGED; ARTICLE; BRAIN FUNCTION; BRAIN REGION; CINGULATE GYRUS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; IMAGE ANALYSIS; MALE; MILD COGNITIVE IMPAIRMENT; MULTICENTER STUDY; NEUROIMAGING; OXYGEN BLOOD LEVEL; PREFRONTAL CORTEX; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL MEMORY;

AGED; CEREBRAL CORTEX; COGNITION DISORDERS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INDANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY; MIDDLE AGED; NOOTROPIC AGENTS; PILOT PROJECTS; PIPERIDINES; PLACEBOS; SEVERITY OF ILLNESS INDEX;

EID: 60049083718     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A1359     Document Type: Article

References (34)

1. Drzezga A. Concept of functional imaging of memory decline in Alzheimer's disease. Methods 2008;44:304-14
2. Ries ML, Carlsson CM, Rowley HA, etal. Magnetic resonance imaging characterization of brain structure and function in mild cognitive impairment: a review. J Am Geriatr Soc 2008;56:920-34
3. Krishnan S, Talley BD, Slavin MJ, et al. Current status of functional MR imaging, perfusion-weighted imaging, and diffusion-tensor imaging in Alzheimer's disease diagnosis and research. Neuroimaging Clin N Am 2005; 15:853-68
4. Saykin AJ, Wishart HA. Mild cognitive impairment: conceptual issues and structural and functional brain correlates. Semin Clin Neuropsychiatry 2003;8:12-30
5. Petrella JR, Coleman RE, Doraiswamy PM. Neuroimaging and early diagnosis of Alzheimer disease: a look to the future. Radiology 2003;226:315-36
6. Dickerson BC, Sperling RA. Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease. NeuroRx 2005;2:348-60
7. Petersen RC, Thomas RG, Grundman M, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005;352:2379-88
8. Salloway S, Ferris S, Kluger A, et al. Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial. Neurology 2004;63: 651-57
9. Venneri A. Imaging treatment effects in Alzheimer's disease. Magn Reson Imaging2007;25:953-68
10. Petrella JR, Lustig C, Bucher LA, et al. Prefrontal activation patterns in subjects at riskfor Alzheimer disease. Am JGeriatr Psychiatry2002;10:112-13
11. Petrella JR, Townsend BA, Jha AP, et al. Increasing memory load modulates regional brain activity in older adults as measured by fMRI. J Neuropsychiatry Clin Neurosci 2005;17:75-83
12. Cabeza R, Nyberg L. Imaging cognition II: an empirical review of 275 PET and fMRI studies. J Cogn Neurosci 2000;12:1-47
13. Prince SE, Daselaar SM, Cabeza R. Neural correlates of relational memory: successful encoding and retrieval of semantic and perceptual associations. J Neurosci 2005;25:1203-10
14. Prince SE, Tsukiura T, Cabeza R. Distinguishing the neural correlates of episodic memory encoding and semantic memory retrieval. Psychol Sci 2007;18: 144 -51
15. Ranganath C, Johnson MK, D'Esposito M. Prefrontal activity associated with working memory and episodic long-term memory. Neuropsychologia 2003;41:378-89
16. Wagner AD, Pare-Blagoev EJ, Clark J, et al. Recovering meaning: left prefrontal cortex guides controlled semantic retrieval. Neuron 2001;31:329-38
17. Mandzia JL, McAndrews MP, Grady CL, et al. Neural correlates of incidental memory in mild cognitive impairment: an fMRI study. Neurobiol Aging 2007 Oct 24. [Epub ahead of print]
18. Rombouts SA, Barkhof F, Van Meel CS, et al. Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease. J Neurol NeurosurgPsychiatry2002;73:665-71
19. Goekoop R, Rombouts SA, Jonker C, et al. Challengingthe cholinergicsystem in mild cognitive impairment: a pharmacological fMRI study. Neuroimage 2004;23:1450 -59
20. Saykin AJ, Wishart HA, Rabin LA, et al. Cholinergic enhancement of frontal lobe activityin mild cognitive impairment. Brain 2004;127:1574 -83
21. Bentley P, Driver J, Dolan RJ. Cholinesterase inhibition modulates visualand attentional brain responses in Alzheimer's disease and health. Brain 2008;131:409 -24
22. Shanks MF, McGeown WJ, Forbes-McKay KE, et al. Regional brain activity after prolonged cholinergic enhancement in early Alzheimer's disease. Magn Reson Imaging2007;25:848 -59
23. Leyhe T, Stransky E, Eschweiler GW, et al. Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer's disease. Eur Arch PsychiatryClin Neurosci 2008;258:124-28
24. Mesulam M. The cholinergic lesion of Alzheimer's disease: pivotal factor or side show? Learn Mem 2004;11:43-49
25. Matthews B, Siemers ER, Mozley PD. Imaging-based measures ofdisease progression in clinical trials of disease-modifying drugs for Alzheimer disease. Am J Geriatr Psychiatry 2003;11:146 -59
26. Tune L, Tiseo PJ, Ieni J, et al. Donepezil HCl (E2020) maintains functional brain activity in patients with Alzheimer disease: results of a 24-week, double- blind, placebo-controlled study. Am J Geriatr Psychiatry 2003;11:169-77
27. Knapp MJ, Knopman DS, Solomon PR, et al. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease: The Tacrine Study Group. JAMA 1994;271:985-91
28. Rogers SL, Farlow MR, Doody RS, et al. A 24-week, double-blind, placebo- controlled trial of donepezil in patients with Alzheimer's disease: Donepezil StudyGroup. Neurology 1998;50:136 -45
29. Tariot PN, Solomon PR, Morris JC, et al. A 5-month, randomized, placebocontrolled trial of galantamine in AD: The Galantamine USA-10 Study Group. Neurology 2000;54:2269 -76
30. Miller MB, Van Horn JD, Wolford GL, et al. Extensive individual differences in brain activations associated with episodic retrieval are reliable over time. J Cogn Neurosci 2002;14:1200-14
31. Kahn I, Davachi L, Wagner AD. Functional-neuroanatomic correlates of recollection: implications for models of recognition memory. J Neurosci 2004;24:4172-80
32. Sperling RA, Bates JF, Cocchiarella AJ, et al. Encoding novel face-name associations: a functional MRI study. Hum Brain Mapp 2001;14:129-39
33. Leube DT, Erb M, Grodd W, et al. Successful episodic memory retrieval of newly learned faces activates a left fronto-parietal network. Brain Res Cogn Brain Res 2003;18:97-101
34. Grady CL, McIntosh AR, Bookstein F, et al. Age-related changes in regional cerebral blood flow during working memory for faces. Neuroimage 1998;8: 409 -25